½ÃÀ庸°í¼­
»óǰÄÚµå
1593528

°ñÀÌ½Ä ´ëü¹° ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®(Àç·á À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°) : »ê¾÷ ¿¹Ãø(2024-2031³â)

Bone Graft Substitutes Market Size, Share, Growth Analysis, By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Joint Reconstruction), By End User, By Region - Industry Forecast 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 219 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °ñÀÌ½ÄÆí°ú ´ë¿ëǰ ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 12¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2023³â 12¾ï 8,000¸¸ ´Þ·¯¿¡¼­ 2031³â¿¡´Â 21¾ï 5,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, ¿¹Ãø ±â°£(2024-2031³â)¿¡ 6.70%ÀÇ CAGR·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ °ñÀÌ½Ä ´ëü¹° ½ÃÀåÀº ÇÕ¼º ´ëüÀçÀÇ Àαâ¿Í ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» ¹ÞÀº Çõ½ÅÀûÀÎ Á¦Ç° Ãâ½Ã·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ú½ºÅͰ¡ 2020³â 7¿ù FDA·ÎºÎÅÍ 'Altapore Shape Bioactive Bone Graft'¸¦ ½ÂÀιÞÀº °ÍÀº ÀÌ·¯ÇÑ Ãß¼¼¸¦ »ó¡ÀûÀ¸·Î º¸¿©ÁÝ´Ï´Ù. »ýü ÀûÇÕ¼º, ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏ, »À Ä¡À¯ ÃËÁøÀ¸·Î ÀÎÇØ °ñÀÌ½ÄÆí°ú ±× ´ëüǰÀÇ »ç¿ëÀÌ Á¡Á¡ ´õ ¼±È£µÇ°í ÀÖÀ¸¸ç, ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ´Â »ýü ÀûÇÕ¼º ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ´«¿¡ ¶ç°Ô ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ÇÏÀ̵å·Ï½Ã¾ÆÆÄŸÀÌÆ®(HAp)¿Í Àλê»ïÄ®½·(TCP)À» ÁÖÀÔÇÑ ÇÕ¼º ÀÌ½ÄÆíÀº ³ôÀº ÀûÇÕ¼ºÀ¸·Î ÀÎÇØ Àαâ ÀÖ´Â ´ëüÀç·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, GraftysÀÇ °ñ°ø±Ø ÃæÀüÁ¦ ÀÎÁõ°ú Molecular MatrixÀÇ Ã·´Ü Osteo-P ÇÕ¼º °ñÀ̽ÄÀç Substitutes°¡ ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. P Synthetic Bone Graft SubstituteÀÇ Ãâ½Ã µîÀÌ ±× ¿¹ÀÔ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ȸº¹½Ã°£ ´ÜÃà, ÀÔ¿ø±â°£ ´ÜÃà, Àý°³Ã¢ Ãà¼Ò µîÀÇ ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ¹Ì±¹ Á¤Çü¿Ü°úÇÐȸ(AAOS) ÀÚ·á¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â °üÀý°æ ¼ö¼ú, ôÃß ¼ö¼ú, °ñÀý ¼ö¼ú, Àΰø°üÀý ġȯ¼ú°ú °°Àº ÃÖ¼Òħ½ÀÀû Á¤Çü¿Ü°ú¼ö¼úÀÌ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ ¸ðµç °ÍÀÌ °ñÀÌ½Ä ´ëü¹° ½ÃÀåÀÇ ¼ºÀå °¡¼ÓÈ­¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

¼­·Ð

  • ºÐ¼® ¸ñÀû
  • Á¤ÀÇ
  • ½ÃÀå ¹üÀ§

ºÐ¼® ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷ µ¥ÀÌÅÍ ¼Ò½º¿Í 1Â÷ µ¥ÀÌÅÍ ¼Ò½º
  • ½ÃÀå ±Ô¸ð ¿¹Ãø
  • ½ÃÀåÀÇ »óÁ¤°ú Á¦ÇÑ

°³¿ä

  • ½ÃÀå °³¿ä¿Í Àü¸Á
  • ¼ö±Þ µ¿Ç⠺м®
  • ºÎ¹®º° ±âȸ ºÐ¼®

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ±âȸ
    • ¾ïÁ¦¿äÀÎ
    • °úÁ¦
  • PorterÀÇ »ê¾÷ ºÐ¼®

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ±â¼ú ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • ½ÃÀåÀÇ ¿¡ÄڽýºÅÛ
  • »ç·Ê ¿¬±¸ ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • Çõ½Å ¸ÅÆ®¸¯½º
  • ÁÖ¿ä ÅõÀÚ ºÐ¼®
  • ÁÖ¿ä ¼º°ø ¿äÀÎ
  • °æÀïÀÇ Á¤µµ

°ñÀÌ½Ä ´ëü¹° ½ÃÀå : Àç·á À¯Çüº°

  • ½ÃÀå °³¿ä
  • µ¿Á¾ÀÌ½ÄÆí
    • DBM(Demineralized Bone Matrix)
    • ±âŸ
  • ÇÕ¼º ÀÌ½ÄÆí
    • ¼¼¶ó¹Í
    • HAp
    • B-TCP
    • a-TCP
    • BCP(Bi-phasic Calcium Phosphates)
    • ±âŸ
    • º¹ÇÕÀç·á
    • Æú¸®¸Ó
    • »ÀÇü¼º ´Ü¹éÁú(BMP)

°ñÀÌ½Ä ´ëü¹° ½ÃÀå : ¿ëµµº°

  • ½ÃÀå °³¿ä
  • µÎ°³¾Ç¾È¸é
  • Ä¡°ú
  • ¹ß¡¤¹ß¸ñ
  • °üÀý Àç°Ç
  • Àå°ñ
  • ôÃß°íÁ¤¼ú

°ñÀÌ½Ä ´ëü¹° ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå °³¿ä
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

°ñÀÌ½Ä ´ëü¹° ½ÃÀå : Áö¿ªº°

  • ½ÃÀå °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
    • °ÉÇÁÇù·ÂȸÀÇ(GCC) ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï ±¸µµ

  • »óÀ§ 5»çÀÇ ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2023³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ½ÃÀå¿¡¼­ÀÇ Ãֱ٠Ȱµ¿
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2023³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • AlloSource(¹Ì±¹)
  • Smith+Nephew(¿µ±¹)
  • Medtronic(Ireland)
  • Orthofix US LLC(¹Ì±¹)
  • Pietro Fiorentini S.p.A.(ÀÌÅ»¸®¾Æ)
  • TBF(ÇÁ¶û½º)
  • OST Laboratories(ÇÁ¶û½º)
  • Geistlich Pharma AG(½ºÀ§½º)
  • Stryker(¹Ì±¹)
  • Biobank(¿µ±¹)
  • Aichi Tokei Denki Co., Ltd.(ÀϺ»)
  • Chongqing Shancheng Gas Equipment Co., Ltd.(Áß±¹)
  • Flonidan A/S(µ§¸¶Å©)
  • EMH metering GmbH & Co. KG(µ¶ÀÏ)
  • Badger Meter, Inc.(¹Ì±¹)
  • Wasion Group Holdings Limited(Star Treasure Investments Holdings Limited) (Áß±¹)
  • Holley Technology Ltd.(Holley Group) (Áß±¹)
  • Qianwei Kromschroder Meters Co., Ltd.(Áß±¹)
  • Secure Meters Limited(Àεµ)
  • IMAC Systems, Inc.(¹Ì±¹)
  • Metrix Meter(Æú¶õµå)
KSA 24.12.02

Global Bone Grafts and Substitutes Market size was valued at USD 1.2 billion in 2022 and is poised to grow from USD 1.28 billion in 2023 to USD 2.15 billion by 2031, growing at a CAGR of 6.70% during the forecast period (2024-2031).

The global market for bone graft substitutes is poised for robust growth driven by the rising preference for synthetic substitutes and the introduction of innovative products approved by regulatory bodies. Notably, Baxter's FDA clearance in July 2020 for its Altapore Shape Bioactive Bone Graft exemplifies this trend. The incorporation of bone grafts and substitutes is increasingly favored due to their biocompatibility, safety profile, and promotion of bone healing, with a notable surge in demand for biocompatible solutions that minimize adverse reactions. Synthetic grafts, particularly those infused with Hydroxyapatite (HAp) and Tricalcium Phosphate (TCP), have emerged as popular alternatives due to their enhanced compatibility. Regulatory support and proactive product development strategies by market players are further bolstering market expansion, highlighted by Graftys' certification of its bone void fillers and Molecular Matrix's launch of the advanced Osteo-P Synthetic Bone Graft Substitute. Additionally, the trend toward minimally invasive procedures enhances the demand for bone grafts due to benefits such as reduced recovery time, shorter hospital stays, and smaller incisions. Data from the American Academy of Orthopedic Surgeons (AAOS) indicates a steady rise in minimally invasive orthopedic procedures in the United States, including arthroscopy, spine surgeries, fracture repairs, and joint replacements, all of which significantly contribute to the accelerated growth of the bone graft substitute market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Grafts And Substitutes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Grafts And Substitutes Market Segmental Analysis

Global Bone Grafts and Substitutes Market is segmented by Material Type, Application, End User and Region. Based on Material Type, the market is segmented into Allograft, Synthetic. Based on Application, the market is segmented into Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, and Spinal Fusion. Based on End User, the market is segmented into Hospitals, Specialty clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Bone Grafts And Substitutes Market

A key market driver for the global bone grafts and substitutes market is the rising prevalence of orthopedic conditions and musculoskeletal disorders, fueled by factors such as sedentary lifestyles, an aging population, and a surge in sports-related injuries and accidents. The increasing incidence of fractures and bone-related ailments has escalated the demand for effective bone graft substitutes that facilitate bone regeneration and healing processes. This growing need emphasizes the urgency for innovative and efficient solutions within the market, aimed at addressing the burgeoning patient population and the complexities associated with a variety of orthopedic conditions, thereby driving market growth and development.

Restraints in the Global Bone Grafts And Substitutes Market

A significant market restraint for the global bone grafts and substitutes market is the high cost associated with these advanced medical products. The utilization of sophisticated technologies and premium materials in developing bone graft substitutes drives their prices up, which can limit their adoption, particularly in emerging economies where healthcare budgets are constrained. Furthermore, inadequate reimbursement coverage for these products within various healthcare systems exacerbates the issue, resulting in reduced accessibility for potential patients. This financial barrier presents a considerable challenge for individuals, healthcare practitioners, and systems striving for cost-effective solutions in managing bone-related ailments, thereby impacting overall market growth.

Market Trends of the Global Bone Grafts And Substitutes Market

The global bone grafts and substitutes market is witnessing a significant trend towards the development of bioactive and tissue-engineered grafts, driven by the need for enhanced biocompatibility and accelerated bone healing. Innovations in technologies like 3D printing and nanotechnology are facilitating the production of tailored graft substitutes that boast superior structural and mechanical properties. This trend underscores the industry's focus on pioneering solutions that closely resemble natural bone tissue, yielding better patient outcomes and minimizing complications associated with traditional bone grafting techniques. As a result, the market is evolving towards more advanced and effective graft options, reflecting a commitment to improving surgical results and patient recovery.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Bone Graft Substitutes Market by Material Type

  • Market Overview
  • Allograft
    • Demineralized Bone Matrix
    • Others
  • Synthetic
    • Ceramics
    • HAP
    • B-TCP
    • a-TCP
    • Bi-phasic Calcium Phosphates (BCP)
    • Others
    • Composites
    • Polymers
    • Bone Morphogenic Proteins (BMP)

Bone Graft Substitutes Market by Application

  • Market Overview
  • Craniomaxillofacial
  • Dental
  • Foot & Ankle
  • Joint Reconstruction
  • Long Bone
  • Spinal Fusion

Bone Graft Substitutes Market by End User

  • Market Overview
  • Hospitals
  • Specialty clinics
  • Others

Bone Graft Substitutes Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • AlloSource (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith + Nephew (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orthofix US LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pietro Fiorentini S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TBF (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OST Laboratories (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Geistlich Pharma AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biobank (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aichi Tokei Denki Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chongqing Shancheng Gas Equipment Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flonidan A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMH metering GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Badger Meter, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wasion Group Holdings Limited (Star Treasure Investments Holdings Limited) (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Holley Technology Ltd. (Holley Group) (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qianwei Kromschroder Meters Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Secure Meters Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IMAC Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metrix Meter (Poland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦